There is no canonical full name for "TP53RK divergent transcript". (None)

"TP53RK divergent transcript" does not refer to a well-characterized molecule, receptor, enzyme, transporter, or protein. The canonical gene, TP53RK (TP53-regulating kinase, PRPK), encodes a serine/threonine kinase and is a constituent of the KEOPS complex, essential for tRNA modification and protein translation efficiency[1]. Pathogenic variants in *TP53RK* are implicated in genetic diseases such as Galloway–Mowat syndrome[1]. The term "divergent transcript" is used for antisense or flanking noncoding RNAs but is not an established therapeutic target, nor does it map to any recognized molecular entity. In summary, **"TP53RK divergent transcript" is not an accepted molecular target or gene product**—all canonical, disease-relevant, and therapeutic information in literature relates to the protein-coding gene TP53RK and its protein PRPK, not to any divergent or noncoding transcript[1][3].

None established for the "divergent transcript".